Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Irish Pharmaceutical Healthcare Association .
Filed returns
182
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2018 | Irish Pharmaceutical Healthcare Association | Health | To arrange meetings with senior Fianna Fáil front benchers, including Party Leader Micheál Martin TD (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2018 | Irish Pharmaceutical Healthcare Association | Health | Fianna Fáil private members bill to amend the Health Act 2013 (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2018 | Irish Pharmaceutical Healthcare Association | Health | IPHA political series with Health Spokspersons (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2018 | Irish Pharmaceutical Healthcare Association | Health | Selfcare policy document developed in cooperation with IPU (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2018 | Irish Pharmaceutical Healthcare Association | Health | Government support and involvement in BioPharma Ambition Conference, February 2018 (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2017 | Irish Pharmaceutical Healthcare Association | Health | Oireachtas Health Committee hearing on Orphan Drugs (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2017 | Irish Pharmaceutical Healthcare Association | Health | The IPHA Annual Conference and Dinner (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2017 | Irish Pharmaceutical Healthcare Association | Health | To challenge claims made in the Sunday Business Post about the effectiveness of some oncology medicines (Public policy or programme) | 17 | On lobbying.ie |
| Sep–Dec 2017 | Irish Pharmaceutical Healthcare Association | Health | To provide briefings for members of the Oireachtas on reimbursement issues (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2017 | Irish Pharmaceutical Healthcare Association | Health | To convey IPHA position on Fianna Fáil private members bill on payments to doctors (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2017 | Irish Pharmaceutical Healthcare Association | Health | To discuss with Fianna Fáil spokesperson on Health topical issues on interest to the IPHA, including slowness in the reimbursement of new medicines, biosimilars and private members bill on payments to doctors (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2017 | Irish Pharmaceutical Healthcare Association | Health | To seek appearance before the Oireachtas Health Committee (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2017 | Irish Pharmaceutical Healthcare Association | Health | Slowness in the reimbursement of new medicines in the Irish health system (Public policy or programme) | 0 | On lobbying.ie |
| May–Aug 2017 | Irish Pharmaceutical Healthcare Association | Health | To determine Government position on European Commission plans to review IP incentives (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2017 | Irish Pharmaceutical Healthcare Association | Health | Briefing of individual members of the Oireachtas on issues of priority to IPHA and its members, including access to new medicines. transparency and the Framework Agreement (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2017 | Irish Pharmaceutical Healthcare Association | Health | To discuss with the Minister for Health Government policy as it relates to the supply and reimbursement of new medicines (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2017 | Irish Pharmaceutical Healthcare Association | Health | To highlight that very serious delays in the assessment process for new medicines was continuing resulting in patients not getting timely access (Public policy or programme) | 0 | On lobbying.ie |
| Jan–Apr 2017 | Irish Pharmaceutical Healthcare Association | Health | Fianna Fáil private members bill on disclosure of payments to medical practitioners (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2017 | Irish Pharmaceutical Healthcare Association | Health | To assist in setting meeting between Minister and Head of Europe of Biogen (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2017 | Irish Pharmaceutical Healthcare Association | Health | The operation of the Framework Agreement and policy issues such as pricing, reimbursement, early access schemes and transparency (Public policy or programme) | 13 | On lobbying.ie |
| Sep–Dec 2016 | Irish Pharmaceutical Healthcare Association | Health | To advise the Fianna Fail Spokesperson on Health and members of the joint Oireachtas Committee on Health of IPHA concerns on a private members bill to amend the Health (Pricing and Supply of Medical Goods) Act 2013 (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2016 | Irish Pharmaceutical Healthcare Association | Health | To update the Minister for Health on policy priorities for the IPHA, including the implementation of the new Pricing and Supply Agreement; the possible relocation of the EMA post Brexit; transfers of value (ToV) issue… (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2016 | Irish Pharmaceutical Healthcare Association | Health | To update the Minister for Jobs, Enterprise and Innovation on policy priorities for IPHA, including the new Pricing and Supply Agreement; importance of fostering innovation; industry's wish to contribute to dialogue on… (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2016 | Irish Pharmaceutical Healthcare Association | Health | Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2015 (Fianna Fáil Private Members Bill) (Legislation) | 4 | On lobbying.ie |
| May–Aug 2016 | Irish Pharmaceutical Healthcare Association | Health | Negotiation of new Medicines Supply Agreement between IPHA and the State (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2016 | Irish Pharmaceutical Healthcare Association | Health | New Supply Agreement between the State and IPHA (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2016 | Irish Pharmaceutical Healthcare Association | Health | European Commission Country Specific Recommendations (CSRs) on Ireland relating to expenditiure on prescription medicines (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2015 | Irish Pharmaceutical Healthcare Association | Health | Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2015 (Fianna Fáil Private Members Bill) (Legislation) | 3 | On lobbying.ie |
| Sep–Dec 2015 | Irish Pharmaceutical Healthcare Association | Health | European Commission Country Specific Recommendations (CSRs) on Ireland related to expenditure on prescription medicines (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2015 | Irish Pharmaceutical Healthcare Association | Health | Report of Oireachtas Committee on Health and Children on the cost of prescription drugs (Public policy or programme) | 22 | On lobbying.ie |
| Sep–Dec 2015 | Irish Pharmaceutical Healthcare Association | Health | Preparations for negotiations on a new Supply Agreement between IPHA and the State (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2015 | Irish Pharmaceutical Healthcare Association | Health | IPHA policy priorities as set out in "Policy and Budgetary Perspectives 2015 - 2016" document (Public policy or programme) | 21 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 182 | 100.0% |